Search

Transmission of monkeypox virus through sexual contact - a novel route of infection. The monkeypox virus (MPXV) that causes the monkeypox (MPX) disease, was first discovered in 1958. Monkeypox outbreak - no panic and stigma; only awareness and preventive measures can halt the pandemic turn of this epidemic infection. [Extracted from the article]

Norovirus, an enteric virus primarily responsible for gastroenteritis outbreaks worldwide, is currently causing outbreaks around the United Kingdom during the COVID‐19 pandemic. With an already exhausted health care system, the significant burden norovirus can have on the National Health Service, including economic and social burdens, is immense and cannot be tolerated. Primary challenges and priorities to be focused on due to the increase in norovirus outbreaks include a further depletion of health care services, increase cases in schools, nurseries, and care facilities, underreporting of the cases, and no effective vaccine being available. Therefore, it is essential to increase awareness about norovirus and its transmission in public, take necessary precautions, and increase reporting of cases. This article discusses the impact norovirus has during the COVID‐19 pandemic, and the challenges, and recommendations to achieve control before it reaches epidemic levels. Highlights: Norovirus outbreaks are increasing in the United Kingdom, with an epidemic potential in the midst of the COVID‐19 pandemic.60% of these outbreaks are occurring in educational settings, nurseries, and childcare facilities.The challenges and priorities for norovirus response include healthcare exhaustion, increased outbreak prevalence in schools, colleges, and child nursing facilities, underreporting of cases and no vaccination for definitive immunity available.Recommendations to tackle the situation include increasing awareness about norovirus and its transmission in public, taking necessary precautions, and increasing reporting of cases. [ABSTRACT FROM AUTHOR]

Ischemic stroke leading to bilateral vision loss in COVID-19 patient - A rare case report Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the main causative agent of coronavirus disease 2019 (COVID-19).1 Besides, progressive atypical respiratory system involvement, other organ systems including the central nervous system have also been affected due to the discernable affinity of the virus towards the angiotensin-converting enzyme 2 (ACE2) receptors2,3 that may result in meningitis, encephalitis or stroke. As a result, we recommended that stroke teams should be cautious of the fact that patients with COVID-19 can present with cerebrovascular accidents or events. [Extracted from the article]

South African geneticists have issued an alarm about a novel coronavirus strain they have been tracking since May 2021.1 They are interested in the C.1.2 variation because it includes a number of genetic changes that are comparable to those discovered in other highly transmissible variants that can bypass vaccination protection to some extent. Precautionary measures for more transmissible C.1.2 COVID-19 variant: A caution for Qatar and the rest of the world REFERENCES 1 Geddes L. What does the new C.1.2 coronavirus variant mean for COVID-19 vaccines?. [Extracted from the article]

SARS-CoV-2 causes Kawasaki-like disease in children: Cases reported in Pakistan The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease (COVID), has spread promptly globally.1,2 In adults, COVID-19 shows classic symptoms that range from severe interstitial pneumonia to hyperactivation of the inflammatory cascade.3 In children, respiratory involvement is mild and has a nonthreatening course, with almost no mortalities.4 Recently, many cases of post-COVID inflammatory syndrome are being reported in Karachi, Lahore, and Islamabad/Rawalpindi, Pakistan.4 It is also known as Kawasaki-like multisystem inflammatory,5 it named because of some similar symptoms with the other rare childhood conditions Kawasaki disease such as skin rash, lymphadenopathy, strawberry tongue, and elevated inflammatory biomarkers.6 The association between COVID-19 and Kawasaki-like multisystem inflammatory syndrome in children (MIS-C) is not well understood.6 The incidence of post-COVID inflammatory syndrome is 1 of 1000 children affected by COVID-19.7 In the present case report, we present a rare and unique manifestation of COVID-19-related Kawasaki symptoms in Pakistani children. As per news report, eight cases of Kawasaki-like multisystem inflammatory syndrome that are associated with COVID-19, have been reported in children between the ages of 5 to 15 years at Children Hospital, Lahore.5 All the affected children have been tested positive for coronavirus antibodies. [Extracted from the article]